Because it targets the circ-OXCT1/miR-136/SMAD4 axis, circ-OXCT1 overexpression may be a potential therapy for advanced gastric cancer, particularly when there are distant metastases as shown in Fig. 3 [91]. Here, OXCT1 is linked to gastric cancer.